Ratings
0
Nobody has rated this yet. Be the first!
Works
6
Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways
Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
